Please assess the completion status of the following clinical trial:

Trial Title: Improving Safety of Antivenom in People Bitten by Snakes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Above 12 years of age~* Patients admitted to hospital after snake bite in whom antivenom is indicated~* Patients who give informed consent~Exclusion Criteria:~* Patients who are pregnant or nursing~* Patients who are currently taking beta- or alpha-adrenoceptor antagonists, or tricyclic antidepressants~* Patients in whom adrenaline may be contraindicated (this may include patients with the following: history of ischaemic heart disease, stroke, uncontrolled hypertension, and tachyarrhythmias)

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).